Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1952 1
1953 2
1954 1
1955 1
1956 2
1957 3
1958 6
1959 9
1960 4
1961 11
1962 12
1963 1
1965 31
1966 78
1967 113
1968 135
1969 169
1970 164
1971 227
1972 229
1973 228
1974 281
1975 268
1976 239
1977 223
1978 231
1979 239
1980 242
1981 246
1982 250
1983 344
1984 426
1985 430
1986 458
1987 507
1988 479
1989 588
1990 575
1991 617
1992 594
1993 672
1994 697
1995 789
1996 767
1997 739
1998 854
1999 821
2000 911
2001 990
2002 1066
2003 1151
2004 1353
2005 1403
2006 1512
2007 1636
2008 1720
2009 1752
2010 2004
2011 2292
2012 2479
2013 2803
2014 3108
2015 3256
2016 3034
2017 3157
2018 3176
2019 1615
2020 33
Text availability
Article attribute
Article type
Publication date

Search Results

50,297 results
Results by year
Filters applied: . Clear all
Page 1
Hepatocellular adenoma: Classification, variants and clinical relevance
Bioulac-Sage P, et al. Semin Diagn Pathol 2017 - Review. PMID 28131467
Hepatocellular adenoma is discovered on a background of liver diseases such as non-alcoholic steatohepatitis, vascular diseases, and alcoholic cirrhosis. ...Liver pathologists and radiologists are the key actors in the identification of the different subtypes of hepatocellular adenoma by the recognition of their specific morphological features. ...
Hepatocellular adenoma is discovered on a background of liver diseases such as non-alcoholic steatohepatitis, vascular diseases, and …
Fatty Liver Disease and Hepatocellular Carcinoma: The Pathologist's View.
Tiniakos DG, et al. Adv Exp Med Biol 2018 - Review. PMID 30362090
Up to 20% of cases of alcohol-associated HCC may develop in pre-cirrhotic liver while HCC is also increasingly recognised in pre-cirrhotic NASH raising questions on appropriate surveillance measures for these patient populations. The recently described steatohepatitic subtype of HCC presents with higher frequency in NAFLD compared to alcoholic liver disease (ALD) patients. ...
Up to 20% of cases of alcohol-associated HCC may develop in pre-cirrhotic liver while HCC is also increasingly recognised in pre-cirr …
Loco-regional treatment of HCC: current status
Crocetti L, et al. Clin Radiol 2017 - Review. PMID 28258743
The treatment choice in patients with HCC is therefore driven not only by tumour staging, as in the great majority of cancers, but also by careful evaluation of liver function and physical status. Another specific feature of HCC is that it is the only tumour that can be cured by organ transplantation, with the aim of treating both the cancer and underlying liver disease. ...
The treatment choice in patients with HCC is therefore driven not only by tumour staging, as in the great majority of cancers, but also by c …
Gender disparity in hepatocellular carcinoma (HCC): multiple underlying mechanisms
Zheng B, et al. Sci China Life Sci 2017 - Review. PMID 28547581
The evidence that both morphology and function of the human liver are affected by sex hormones was found over 60 years ago. However, the underlying molecular mechanism largely remains to be elucidated. ...
The evidence that both morphology and function of the human liver are affected by sex hormones was found over 60 years ago. However, …
Personalized treatment of patients with very early hepatocellular carcinoma
Vitale A, et al. J Hepatol 2017 - Review. PMID 27677712
According to extent of liver resection, and liver function, percutaneous ablation or liver resection are the recommended first line therapies in these patients. Laparoscopic surgery (resection or ablation) is the preferable strategy when the tumor is in the surface of the liver or close to extra-hepatic organs. ...
According to extent of liver resection, and liver function, percutaneous ablation or liver resection are the recommende …
Hepatic Progenitor Cells: An Update
Van Haele M and Roskams T. Gastroenterol Clin North Am 2017 - Review. PMID 28506372
Liver regeneration is a fascinating and complex process with many medical implications. An important component of this regenerative process is the hepatic progenitor cell (HPC). ...New findings indicate that the regenerative possibilities in the liver could provide a diverse basis for therapeutic targets....
Liver regeneration is a fascinating and complex process with many medical implications. An important component of this regenerative p
Immunotherapy for hepatocellular carcinoma patients: is it ready for prime time?
Obeid JM, et al. Cancer Immunol Immunother 2018 - Review. PMID 29052780
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and the second most common cause of cancer death worldwide. ...However, a major barrier to the development and success of immunotherapy in patients with HCC is the liver's inherent immunosuppressive function. ...
Hepatocellular carcinoma (HCC) is the most common primary liver malignancy and the second most common cause of cancer death worldwide …
Study of liver in HBV-related hepatocellular carcinoma: Stereology shows quantitative differences in liver structure.
Moudi B, et al. Eur J Histochem 2018. PMID 30223640 Free PMC article.
Hepatocellular carcinoma is one of the main consequences of liver chronic disease. Hepatocellular carcinoma-related changes may be seen in patients with chronic hepatitis B. ...It is useful for assessing the liver tissue parameters. Stereology is recommended for the diagnosis of people prone to cancer in patients with chronic hepatitis B....
Hepatocellular carcinoma is one of the main consequences of liver chronic disease. Hepatocellular carcinoma-related changes may be se …
50,297 results
Jump to page
Feedback